Table 1.
Clinical and Demographic Characteristics of the Sample
| Pre-Hospitalization Antiplatelet Use |
p-value | ||
|---|---|---|---|
| Non-Users (n = 524) | Users (n = 239) | ||
| Age, years | 58.5 ± 16.2 | 69.6 ± 12.5 | <0.0001 |
| Sex, female | 239 (45.70) | 95 (39.75) | 0.125 |
| BMIa, kg/m2 | 30.0 ± 7.4 | 29.0 ± 6.5 | 0.137 |
| Smoker | 161 (30.78) | 117 (48.95) | <0.0001 |
| HIV | 16 (3.06) | 6 (2.51) | 0.675 |
| Stroke or TIAb | 24 (4.59) | 39 (16.32) | <0.0001 |
| Diabetes mellitus | 152 (29.06) | 139 (58.16) | <0.0001 |
| Hypertension | 258 (49.33) | 214 (89.54) | <0.0001 |
| Coronary artery disease | 32 (6.12) | 100 (41.84) | <0.0001 |
| Heart failure | 32 (6.12) | 45 (18.83) | <0.0001 |
| COPDc | 36 (6.88) | 15 (6.28) | 0.756 |
| Chronic kidney disease | 65 (12.43) | 70 (29.29) | <0.0001 |
| Peripheral vascular disease | 12 (2.29) | 25 (10.46) | <0.0001 |
a
BMI = body mass index
b
TIA = transient ischemic attack
c
COPD = chronic obstructive pulmonary disease.